Royalty Pharma (RPRX) Net Margin Growth (1y) (2020 - 2026)
Royalty Pharma (RPRX) Net Margin Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -185.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -763.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 447.00 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 673.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,097.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -392.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2,208.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 29,636.00 |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -392.00 |
| Mar 31, 2026 | -219.00 |
| Dec 31, 2025 | 90.00 |
| Sep 30, 2025 | -6,989.00 |
| Jun 30, 2025 | -2,052.00 |
| Mar 31, 2025 | 7,720.00 |
| Dec 31, 2024 | -6,406.00 |
| Sep 30, 2024 | 12,003.00 |
| Jun 30, 2024 | -2,910.00 |
| Mar 31, 2024 | -7,518.00 |
| Dec 31, 2023 | 22,821.00 |
| Sep 30, 2023 | -1,567.00 |
| Jun 30, 2023 | -2,644.00 |
| Mar 31, 2023 | 5,164.00 |
| Dec 31, 2022 | -11,715.00 |
| Sep 30, 2022 | 57.00 |
| Jun 30, 2022 | -5,365.00 |
| Mar 31, 2022 | -496.00 |
| Dec 31, 2021 | -5,476.00 |
| Sep 30, 2021 | -7,808.00 |